NIH and drugmaker Eli Lilly begin trials for lab-produced coronavirus antibodies
The National Institutes of Health and U.S. drug maker Eli Lilly are beginning two trials for lab-produced coronavirus antibodies. Dr. Jon LaPook joins “CBS This Morning” to talk about how significant this could be.